JPM 2022: Dexcom, Edwards, J&J, Medtronic, ResMed

The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022 as they continue to cope with the impact of the Omicron surge. Here are some of the highlights from the presentations on the first day of the meeting.

J.P. Morgan Daily Notebook 2022 Day 1
• Source: Alamy

Dexcom CEO Kevin Sayer told investors during his presentation at today’s J.P. Morgan Healthcare Conference that clinical data from the G7 continuous glucose monitoring system exceeded all expectations.

“The performance of this product is something I really never thought I would see in nearly 30 years in this...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Strategy

More from Business